Hypertension News

The combination of healthy lifestyle and adherence to antihypertensive medications was associated with decreased risk for mortality in patients with hypertension, according to data in JAMA Network Open.

The rate of hospitalization for hypertensive crisis increased in recent years, but the odds of death during hospitalization decreased and was similar for men and women, researchers reported.

In a real-world outpatient population, mineralocorticoid receptor antagonist use in patients with chronic kidney disease was associated with lower rates of renal replacement therapy initiation compared with nonuse, researchers reported.

Chronic hypertension is a substantial contributor to maternal deaths in the United States, with particular risk among Black women, according to a study published in Hypertension.

According to a research letter published in Kidney Medicine, kidney function decline correlated with higher nocturnal blood pressure among patients with chronic kidney disease.

Increased exposure to air pollution may lead to higher risk for myocardial fibrosis in patients with chronic kidney disease, according to a speaker at ASN Kidney Week.

Chlorthalidone proved effective in the treatment of persistent hypertension in patients with advanced chronic kidney disease, according to the data presented at ASN Kidney Week.

Compared with other models, N-terminal pro-brain natriuretic peptide is a low burden approach that gives the most “moderate discrimination” while predicting heart failure in patients with chronic kidney disease, data at ASN Kidney Week show.

Data presented at virtual 2021 ASN Kidney Week suggests “intensive blood pressure control” may reduce the risk of heart failure in patients with chronic kidney disease.

Adding a new medication to older adults’ antihypertension treatment regimen produced a slightly greater reduction in systolic BP than maximizing dosage, according to findings published in Annals of Internal Medicine.